Ophthalmic drugs are extensively used to treat glaucoma, cataract, diabetic retinopathy, and other ophthalmic disorders. Introduction of novel ocular drug delivery approaches in the market has driven the manufacturers to develop innovative therapeutic approaches for the treatment of ophthalmic disorders.
The other key factors that boost the ophthalmic drug market size include high prevalence of glaucoma worldwide and rise in transition towards development of combination therapies for the treatment of glaucoma.
Market Analysis and Insights: Global and United States Ophthalmic Drugs Market
This report focuses on global and United States Ophthalmic Drugs QYR Global and United States market.
The global Ophthalmic Drugs market size is projected to reach US$ 26300 million by 2026, from US$ 22990 million in 2020, at a CAGR of 2.3% during 2021-2026.
Global Ophthalmic Drugs Scope and Market Size
Ophthalmic Drugs market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Ophthalmic Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Segment by Type, the Ophthalmic Drugs market is segmented into
Anti-allergy
Anti-VEGF Agents
Anti-inflammatory
Anti-glaucoma
Segment by Application, the Ophthalmic Drugs market is segmented into
Hospital
Clinic
Pharmacy
Regional and Country-level Analysis
The Ophthalmic Drugs market is analysed and market size information is provided by regions (countries).
The key regions covered in the Ophthalmic Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Ophthalmic Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Ophthalmic Drugs business, the date to enter into the Ophthalmic Drugs market, Ophthalmic Drugs product introduction, recent developments, etc.
The major vendors covered:
Santen Pharmaceutical
Bausch Health
Takeda
Novartis
Genentech
Allergan
Sun Pharmaceutical Industries
Actavis Generics
Regeneron Pharmaceuticals
Pfizer
Johnson and Johnson
Bausch and Lomb
The other key factors that boost the ophthalmic drug market size include high prevalence of glaucoma worldwide and rise in transition towards development of combination therapies for the treatment of glaucoma.
Market Analysis and Insights: Global and United States Ophthalmic Drugs Market
This report focuses on global and United States Ophthalmic Drugs QYR Global and United States market.
The global Ophthalmic Drugs market size is projected to reach US$ 26300 million by 2026, from US$ 22990 million in 2020, at a CAGR of 2.3% during 2021-2026.
Global Ophthalmic Drugs Scope and Market Size
Ophthalmic Drugs market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Ophthalmic Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Segment by Type, the Ophthalmic Drugs market is segmented into
Anti-allergy
Anti-VEGF Agents
Anti-inflammatory
Anti-glaucoma
Segment by Application, the Ophthalmic Drugs market is segmented into
Hospital
Clinic
Pharmacy
Regional and Country-level Analysis
The Ophthalmic Drugs market is analysed and market size information is provided by regions (countries).
The key regions covered in the Ophthalmic Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape
and Ophthalmic Drugs Market Share AnalysisOphthalmic Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Ophthalmic Drugs business, the date to enter into the Ophthalmic Drugs market, Ophthalmic Drugs product introduction, recent developments, etc.
The major vendors covered:
Santen Pharmaceutical
Bausch Health
Takeda
Novartis
Genentech
Allergan
Sun Pharmaceutical Industries
Actavis Generics
Regeneron Pharmaceuticals
Pfizer
Johnson and Johnson
Bausch and Lomb
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.